Britain approves the binary new crown vaccine that can be targeted at Omiko's strains

The British Drugs and Health Products Administration approved the binary new crown vaccine made by the United States Modner on the 15th as an adult -enhanced needle.Poison.

In one statement on the same day, the British Drugs and Health Products Administration said that in each dose of the newly approved Modner binary new crown vaccine, half of the dose (25 micrograms) for the original new crown strain, the other half of the dose (25 25 (25Micro) For the mutant new coronary virus Omircong strain.

The statement said that the decision to approve this vaccine is based on clinical trial data.The test data shows that the use of Modner binary vaccines for strengthening needles can cause strong immune response to the original new crown strain and Omikon subtype BA.1.Explorer analysis also found that this two -price vaccine can also produce good immune response to Omikon subtype BA.4 and BA.5.

Balte Campman, director of the vaccine center of the University of London's Hygiene and Tropical Medical College, said: "The emergence of a two -valent (new crown) vaccine is a good news, but how much change it can bring is still to be observed."

- END -